Theralase Technologies Inc (TLTFF)

[-3]

Current average cost is 100 to 200 thous . Mercy !

" The cost to treat a patient with this disease ranges from $USD 100,000 to 200,000. The disease has an 80% recurrence rate. 70% of new bladder cancer cases are early stage disease affecting the inner lining of the bladder (urothelium) and are known as Non-Muscle Invasive Bladder Cancer (“NMIBC”). According to the latest clinical research, 25% of these patients will have a recurrence of the disease within 6 months and a total of 50% recur within 2 years "

http://theralase.com/pressrelease/theralase-achieves-98-destruction-of-bladder-cancer/